| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |